Duloxetine

• A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised
  2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
• Feasibility of short-term temporary discontinuation of serotonin reuptake inhibitors in patients planned for hip or knee arthroplasty Not authorised
  2023-509988-24-00 Phase III/IV 1 country Sygehus Lillebaelt Vejle Sygehus
• EORTC 2237-BCG-QLG: Improvement of Quality of Life through supportive treatments for Endocrine Therapy – related symptoms in patients with e… Not authorised
  2024-513442-10-00 Phase III 5 countries Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europ…
• Clinical trial to evaluate the effectiveness and efficiency of a pre-emptive pharmacogenetic strategy for antidepressant selection in patien… Pending
  2025-522967-13-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting
  2023-506617-21-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
• Efficacy of perioperative duloxetine in patients at high risk for developing chronic postsurgical pain after inguinal hernia repair: a multi… Recruiting
  2023-505860-12-00 Phase III 1 country Parc De Salut Mar
• EDULOX 2- Patientundervisning og medicinsk behandling (duloxetin/aktiv placebo) til patienter med svær funktionel lidelse: et randomiseret, … Recruiting
  2024-514264-42-00 Phase IV 1 country Region Midtjylland
• Capsaicin 179 mg patch versus oral Duloxetine in patients with chemotherapy-induced peripheral neuropathy: a phase 3 randomized multicentric… Recruiting
  2023-504618-31-00 Phase III 1 country Institut De Cancerologie De L Ouest
• Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended
  2022-500538-27-00 Phase II/III 6 countries Otsuka Pharmaceutical Development And Commercialization Inc.
• A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyne… Ended
  2024-511008-17-00 Phase IV 1 country Leids Universitair Medisch Centrum (LUMC)

Showing 1–10 of 10 trials